Ralph Vance

2.0k total citations
49 papers, 1.6k citations indexed

About

Ralph Vance is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Ralph Vance has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 11 papers in Surgery. Recurrent topics in Ralph Vance's work include Lung Cancer Treatments and Mutations (12 papers), Ovarian cancer diagnosis and treatment (9 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Ralph Vance is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Ovarian cancer diagnosis and treatment (9 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Ralph Vance collaborates with scholars based in United States and Canada. Ralph Vance's co-authors include Tawfiq Khansur, Tate Thigpen, Nicholas J. Shaheen, Evan S. Dellon, Hannah P. Kim, J.T. Thigpen, Lodovico Balducci, S E Rivkin, W. J. Stuckey and T Fleming and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer.

In The Last Decade

Ralph Vance

47 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralph Vance United States 18 720 699 466 197 191 49 1.6k
A Gerbaulet France 25 381 0.5× 830 1.2× 347 0.7× 382 1.9× 575 3.0× 65 1.7k
Marshall S. Flam United States 23 977 1.4× 1.5k 2.1× 704 1.5× 77 0.4× 103 0.5× 59 2.2k
Deborah Driscoll United States 23 415 0.6× 328 0.5× 630 1.4× 178 0.9× 99 0.5× 34 1.6k
Moshe Stein Israel 22 468 0.7× 501 0.7× 552 1.2× 103 0.5× 40 0.2× 103 1.5k
Shigeo Aizawa Japan 16 420 0.6× 321 0.5× 407 0.9× 142 0.7× 57 0.3× 56 1.3k
Terue Okamura Japan 21 358 0.5× 419 0.6× 262 0.6× 122 0.6× 165 0.9× 71 1.4k
Renate Pichler Austria 26 670 0.9× 1.0k 1.5× 491 1.1× 139 0.7× 49 0.3× 142 2.0k
F. A. Beale Canada 16 183 0.3× 499 0.7× 263 0.6× 349 1.8× 295 1.5× 18 1.2k
John V. Brown United States 21 222 0.3× 517 0.7× 427 0.9× 639 3.2× 479 2.5× 102 1.6k
Thomas Kuhnt Germany 23 564 0.8× 412 0.6× 463 1.0× 36 0.2× 119 0.6× 80 1.6k

Countries citing papers authored by Ralph Vance

Since Specialization
Citations

This map shows the geographic impact of Ralph Vance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Vance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Vance more than expected).

Fields of papers citing papers by Ralph Vance

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Vance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Vance. The network helps show where Ralph Vance may publish in the future.

Co-authorship network of co-authors of Ralph Vance

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Vance. A scholar is included among the top collaborators of Ralph Vance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Vance. Ralph Vance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dang, Duyen T., Ralph Vance, Andrew Watson, et al.. (2021). Outcomes of cold snare piecemeal EMR for nonampullary small-bowel adenomas larger than 1 cm: a retrospective study. Gastrointestinal Endoscopy. 95(6). 1176–1182. 15 indexed citations
2.
Vance, Ralph. (2015). Endoscopic options for treatment of dysplasia in Barrett’s esophagus. World Journal of Gastrointestinal Endoscopy. 7(19). 1311–1311. 3 indexed citations
3.
Rose, Steven C., Patricia A. Thistlethwaite, Patrick E. Sewell, & Ralph Vance. (2006). Lung Cancer and Radiofrequency Ablation. Journal of Vascular and Interventional Radiology. 17(6). 927–951. 75 indexed citations
4.
West, Howard, Wilbur A. Franklin, Jason McCoy, et al.. (2006). Gefitinib Therapy in Advanced Bronchioloalveolar Carcinoma: Southwest Oncology Group Study S0126. Journal of Clinical Oncology. 24(12). 1807–1813. 114 indexed citations
5.
West, Howard, John J. Crowley, Ralph Vance, et al.. (2005). Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study. Annals of Oncology. 16(7). 1076–1080. 54 indexed citations
6.
Zlowodzki, Michael, et al.. (2005). CASE REPORTS: Malignant Fibrous Histiocytoma of Bone Arising in Chronic Osteomyelitis. Clinical Orthopaedics and Related Research. 439(&NA;). 269–273. 4 indexed citations
7.
Vance, Ralph. (2005). The Asian-American and Pacific Islander population and the American Cancer Society initiative. Cancer. 104(S12). 2905–2908. 1 indexed citations
8.
West, Howard, W. Franklin, Paul H. Gumerlock, et al.. (2004). Gefitinib (ZD1839) therapy for advanced bronchioloalveolar lung cancer (BAC): Southwest Oncology Group (SWOG) Study S0126. Journal of Clinical Oncology. 22(14_suppl). 7014–7014. 8 indexed citations
9.
Taylor, Sarah A., Cathryn Rankin, Jeannette J. Townsend, et al.. (2002). Phase II Trial of Amonafide in Central Nervous System Tumors: A Southwest Oncology Group Study. Investigational New Drugs. 20(1). 113–115. 4 indexed citations
10.
Vance, Ralph, John J. Crowley, & David R. Gandara. (2000). Phase II evaluation of paclitaxel by 96-hour infusion in stage IIIb and IV bronchioloalveolar carcinoma (BAC). Lung Cancer. 29(1). 7–7. 4 indexed citations
11.
Thigpen, J.T., et al.. (1999). Basal Cell Carcinoma With Lung Metastasis Diagnosed by Fine-Needle Aspiration Biopsy. Southern Medical Journal. 92(3). 321–324. 12 indexed citations
12.
Vance, Ralph, et al.. (1998). Patient‐Family‐Staff Dynamics: When the Patient/Family Are Colleagues. Cancer Practice. 6(5). 258–261. 2 indexed citations
13.
Thigpen, Tate, et al.. (1997). The Role of Chemotherapy in the Management of Celomic Epithelial Carcinoma of the Ovary. Cancer Investigation. 15(3). 277–287. 5 indexed citations
14.
Thigpen, Tate, et al.. (1994). Chemotherapy in Advanced Ovarian Carcinoma: Current Standards of Care Based on Randomized Trials. Gynecologic Oncology. 55(3). S97–S107. 48 indexed citations
15.
16.
Vance, Ralph, John J. Crowley, John S. Macdonald, & Frederick R. Ahmann. (1991). Phase II evaluation of menogaril (NSC-269148) in non-small cell lung carcinoma. Investigational New Drugs. 9(1). 73–75. 1 indexed citations
17.
Thigpen, Tate, Ralph Vance, Lodovico Balducci, et al.. (1987). Chemotherapy for advanced or recurrent gynecologic cancer. Cancer. 60(S8). 2104–2116. 59 indexed citations
18.
McCracken, Joseph D., et al.. (1987). Concommittant chemo radiotherapy in limited smallcell carcinoma of lung: Improved response and median survival. A southwest oncology group study. International Journal of Radiation Oncology*Biology*Physics. 13. 188–188. 1 indexed citations
19.
Vance, Ralph, et al.. (1983). Phase II evaluation of MGBG in non-small cell carcinoma of the lung. Investigational New Drugs. 1(1). 89–93. 4 indexed citations
20.
Thigpen, Tate, Ralph Vance, Lodovico Balducci, & John A. Blessing. (1981). Chemotherapy in the management of advanced or recurrent cervical and endometrial carcinoma. Cancer. 48(S1). 658–665. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Gerbaulet Breakdown of academic impact, for papers by Marshall S. Flam Breakdown of academic impact, for papers by Deborah Driscoll Breakdown of academic impact, for papers by Moshe Stein Breakdown of academic impact, for papers by Shigeo Aizawa Breakdown of academic impact, for papers by Terue Okamura Breakdown of academic impact, for papers by Renate Pichler Breakdown of academic impact, for papers by F. A. Beale Breakdown of academic impact, for papers by John V. Brown Breakdown of academic impact, for papers by Thomas Kuhnt
Rankless by CCL
2026